Option Care Health (NASDAQ:OPCH) Hits New 1-Year High – What’s Next?

Shares of Option Care Health, Inc. (NASDAQ:OPCH) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $35.46 and last traded at $34.97, with a volume of 529 shares traded. The stock had previously closed at $34.58.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on OPCH. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price for the company. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Trading Up 1.4 %

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.78 billion, a PE ratio of 29.56, a PEG ratio of 2.30 and a beta of 1.33. The firm’s fifty day moving average is $32.11 and its two-hundred day moving average is $28.33.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

Hedge funds have recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp bought a new stake in Option Care Health in the 4th quarter valued at about $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its stake in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after buying an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after acquiring an additional 332 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.